BEAM logo

Beam Therapeutics (BEAM) Free cash flow

annual FCF:

-$356.19M-$173.26M(-94.72%)
December 31, 2024

Summary

  • As of today (July 4, 2025), BEAM annual free cash flow is -$356.19 million, with the most recent change of -$173.26 million (-94.72%) on December 31, 2024.
  • During the last 3 years, BEAM annual FCF has fallen by -$243.11 million (-214.99%).
  • BEAM annual FCF is now -1247.99% below its all-time high of -$26.42 million, reached on December 31, 2022.

Performance

BEAM Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMcash flow metrics

quarterly FCF:

-$106.95M-$27.61M(-34.81%)
March 31, 2025

Summary

  • As of today (July 4, 2025), BEAM quarterly free cash flow is -$106.95 million, with the most recent change of -$27.61 million (-34.81%) on March 31, 2025.
  • Over the past year, BEAM quarterly FCF has dropped by -$4.76 million (-4.66%).
  • BEAM quarterly FCF is now -150.63% below its all-time high of $211.23 million, reached on March 31, 2022.

Performance

BEAM quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMcash flow metrics

TTM FCF:

-$360.96M-$4.76M(-1.34%)
March 31, 2025

Summary

  • As of today (July 4, 2025), BEAM TTM free cash flow is -$360.96 million, with the most recent change of -$4.76 million (-1.34%) on March 31, 2025.
  • Over the past year, BEAM TTM FCF has dropped by -$191.68 million (-113.23%).
  • BEAM TTM FCF is now -343.55% below its all-time high of $148.21 million, reached on March 31, 2022.

Performance

BEAM TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

BEAM Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-94.7%-4.7%-113.2%
3 y3 years-215.0%-150.6%-343.6%
5 y5 years-321.4%-251.4%-283.9%

BEAM Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1248.0%at low-181.3%+7.7%-393.5%+7.9%
5 y5-year-1248.0%at low-150.6%+7.7%-343.6%+7.9%
alltimeall time-1248.0%at low-150.6%+7.7%-343.6%+7.9%

BEAM Free cash flow History

DateAnnualQuarterlyTTM
Mar 2025
-
-$106.95M(+34.8%)
-$360.96M(+1.3%)
Dec 2024
-$356.19M(+94.7%)
-$79.33M(-11.6%)
-$356.19M(+145.0%)
Sep 2024
-
-$89.70M(+5.6%)
-$145.37M(-5.2%)
Jun 2024
-
-$84.97M(-16.8%)
-$153.40M(-9.4%)
Mar 2024
-
-$102.19M(-177.7%)
-$169.28M(-7.5%)
Dec 2023
-$182.93M(+592.3%)
$131.48M(-234.5%)
-$182.93M(-53.3%)
Sep 2023
-
-$97.73M(-3.1%)
-$391.86M(+3.0%)
Jun 2023
-
-$100.85M(-12.9%)
-$380.41M(+7.6%)
Mar 2023
-
-$115.83M(+49.6%)
-$353.49M(+1237.7%)
Dec 2022
-$26.42M(-76.6%)
-$77.45M(-10.2%)
-$26.42M(-166.9%)
Sep 2022
-
-$86.28M(+16.7%)
$39.49M(-67.9%)
Jun 2022
-
-$73.92M(-135.0%)
$123.00M(-17.0%)
Mar 2022
-
$211.23M(-1930.6%)
$148.21M(-231.1%)
DateAnnualQuarterlyTTM
Dec 2021
-$113.08M(+0.9%)
-$11.54M(+316.1%)
-$113.08M(-15.6%)
Sep 2021
-
-$2.77M(-94.3%)
-$133.96M(-13.7%)
Jun 2021
-
-$48.71M(-2.7%)
-$155.22M(+17.8%)
Mar 2021
-
-$50.06M(+54.4%)
-$131.72M(+17.5%)
Dec 2020
-$112.10M(+32.6%)
-$32.42M(+34.9%)
-$112.10M(+12.5%)
Sep 2020
-
-$24.03M(-4.7%)
-$99.64M(+6.0%)
Jun 2020
-
-$25.20M(-17.2%)
-$94.01M(+8.4%)
Mar 2020
-
-$30.44M(+52.5%)
-$86.75M(+2.6%)
Dec 2019
-$84.52M(+152.9%)
-$19.96M(+8.4%)
-$84.52M(+30.9%)
Sep 2019
-
-$18.41M(+2.6%)
-$64.56M(+39.9%)
Jun 2019
-
-$17.94M(-36.4%)
-$46.15M(+63.6%)
Mar 2019
-
-$28.21M
-$28.21M
Dec 2018
-$33.42M
-
-

FAQ

  • What is Beam Therapeutics annual free cash flow?
  • What is the all time high annual FCF for Beam Therapeutics?
  • What is Beam Therapeutics annual FCF year-on-year change?
  • What is Beam Therapeutics quarterly free cash flow?
  • What is the all time high quarterly FCF for Beam Therapeutics?
  • What is Beam Therapeutics quarterly FCF year-on-year change?
  • What is Beam Therapeutics TTM free cash flow?
  • What is the all time high TTM FCF for Beam Therapeutics?
  • What is Beam Therapeutics TTM FCF year-on-year change?

What is Beam Therapeutics annual free cash flow?

The current annual FCF of BEAM is -$356.19M

What is the all time high annual FCF for Beam Therapeutics?

Beam Therapeutics all-time high annual free cash flow is -$26.42M

What is Beam Therapeutics annual FCF year-on-year change?

Over the past year, BEAM annual free cash flow has changed by -$173.26M (-94.72%)

What is Beam Therapeutics quarterly free cash flow?

The current quarterly FCF of BEAM is -$106.95M

What is the all time high quarterly FCF for Beam Therapeutics?

Beam Therapeutics all-time high quarterly free cash flow is $211.23M

What is Beam Therapeutics quarterly FCF year-on-year change?

Over the past year, BEAM quarterly free cash flow has changed by -$4.76M (-4.66%)

What is Beam Therapeutics TTM free cash flow?

The current TTM FCF of BEAM is -$360.96M

What is the all time high TTM FCF for Beam Therapeutics?

Beam Therapeutics all-time high TTM free cash flow is $148.21M

What is Beam Therapeutics TTM FCF year-on-year change?

Over the past year, BEAM TTM free cash flow has changed by -$191.68M (-113.23%)
On this page